芦可替尼软膏不同版本一盒的最新价格公布

Introduction: Ruxolitinib ointment is a drug used to treat skin diseases such as atopic dermatitis and has attracted much attention due to its remarkable efficacy. The prices of different versions of ruxolitinib ointment vary greatly. The European version is more expensive, while the Bangladeshi version has more price advantages.

The latest prices for a box of different versions of ruxolitinib ointment are announced

There are many versions around the world, and the prices vary depending on the production location and specifications. The following is the latest price information for different versions of ruxolitinib ointment in 2025, for reference only.

Price of the European version of ruxolitinib ointment

The European version of ruxolitinib ointment is available in a box of 100g and costs approximately US$1,492. This version has a higher price, is mainly aimed at the European market, and is suitable for patients who have higher requirements for drug quality.

Price of the Bangladeshi generic version

The price of the ruxolitinib ointment imitated by Istar in Bangladesh is about US$55 per box, while the generic version of Bangladesh Yaopin International is 30mg per box, priced at about US$77. These generic versions of drugs are more affordable and provide patients with more choices.

The prices of different versions of ruxolitinib ointment vary greatly, and patients can choose a suitable version according to their own economic conditions and doctor's recommendations.

The domestic marketing status of ruxolitinib ointment

The domestic marketing status of ruxolitinib ointment has attracted much attention, and many patients are looking forward to purchasing this drug through formal channels. The following is the latest information on the domestic launch of ruxolitinib ointment.

Domestic launch time

Ruxolitinib ointment has not yet been officially launched in mainland China, but it has been launched in Hong Kong, China. Patients can purchase this drug at local hospital pharmacies or regular pharmacies.

Domestic market price

The price of ruxolitinib ointment on the domestic market is similar to the international market price. The specific price varies depending on regions and hospital policies.

The domestic launch of ruxolitinib ointment provides patients with more convenience, and patients can purchase this drug through regular channels.

The medical insurance reimbursement status of ruxolitinib ointment

The medical insurance reimbursement policy of ruxolitinib ointment has an important impact on the financial burden of patients. The following is the latest status of the medical insurance reimbursement of ruxolitinib ointment.

Inclusion in medical insurance

Ruxolitinib ointment has not yet been included in the national medical insurance catalog, and part of the cost cannot be reimbursed through medical insurance.

Price after reimbursement

Ruxolitinib ointment cannot be reimbursed by medical insurance, and patients need to purchase the drug at their own expense. Patients can purchase a suitable version of ruxolitinib ointment according to their own conditions and use it under the guidance of a doctor.